Aceves-Franco L, Sanchez-Aguilar O, Barragan-Arias A, Ponce-Gallegos M, Navarro-Partida J, Santos A
Biomedicines. 2023; 11(7).
PMID: 37509540
PMC: 10377205.
DOI: 10.3390/biomedicines11071901.
Cui X, Ma J, Zeng T, Xu J, Li Y, Wang X
RSC Adv. 2022; 11(39):24247-24253.
PMID: 35479033
PMC: 9036825.
DOI: 10.1039/d1ra04319f.
Zhang J, Jiao J, Niu M, Gao X, Zhang G, Yu H
Int J Nanomedicine. 2021; 16:6497-6530.
PMID: 34588777
PMC: 8473849.
DOI: 10.2147/IJN.S329831.
Chu H, Sethy B, Hsieh P, Horng J
Viruses. 2021; 13(9).
PMID: 34578337
PMC: 8473112.
DOI: 10.3390/v13091756.
Ibrahim M, Abd-Elgawad A, Soliman O, Jablonski M
Transl Vis Sci Technol. 2015; 4(3):12.
PMID: 26175958
PMC: 4497485.
DOI: 10.1167/tvst.4.3.12.
Nanomedicine approaches for corneal diseases.
Chaurasia S, Lim R, Lakshminarayanan R, Mohan R
J Funct Biomater. 2015; 6(2):277-98.
PMID: 25941990
PMC: 4493512.
DOI: 10.3390/jfb6020277.
Novel topical ophthalmic formulations for management of glaucoma.
Ibrahim M, Abd-Elgawad A, Soliman O, Jablonski M
Pharm Res. 2013; 30(11):2818-31.
PMID: 23771565
DOI: 10.1007/s11095-013-1109-1.
Nanotechnology approaches for ocular drug delivery.
Xu Q, Kambhampati S, Kannan R
Middle East Afr J Ophthalmol. 2013; 20(1):26-37.
PMID: 23580849
PMC: 3617524.
DOI: 10.4103/0974-9233.106384.
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.
Natarajan J, Chattopadhyay S, Ang M, Darwitan A, Foo S, Zhen M
PLoS One. 2011; 6(9):e24513.
PMID: 21931735
PMC: 3170360.
DOI: 10.1371/journal.pone.0024513.
Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin.
Hosny K
AAPS PharmSciTech. 2009; 10(4):1336-42.
PMID: 19902361
PMC: 2799601.
DOI: 10.1208/s12249-009-9335-x.
Liposomes as delivery systems in the prevention and treatment of infectious diseases.
Bergers J, Ten Hagen T, Van Etten E
Pharm World Sci. 1995; 17(1):1-11.
PMID: 7719272
DOI: 10.1007/BF01875551.
Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.
Gregoriadis G, Florence A
Drugs. 1993; 45(1):15-28.
PMID: 7680982
DOI: 10.2165/00003495-199345010-00003.
Liposomes in treatment of infectious diseases.
Emmen F, Storm G
Pharm Weekbl Sci. 1987; 9(3):162-71.
PMID: 3302929
DOI: 10.1007/BF01967536.
Evaluation of liposome-encapsulated clindamycin in Staphylococcus aureus endophthalmitis.
Rao V, Peyman G, Khoobehi B, Vangipuram S
Int Ophthalmol. 1989; 13(3):181-5.
PMID: 2793311
DOI: 10.1007/BF02028207.
Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles.
Davies N, Farr S, Hadgraft J, Kellaway I
Pharm Res. 1992; 9(9):1137-44.
PMID: 1409394
DOI: 10.1023/a:1015891419676.
Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial.
Diaz-Llopis M, Martos M, Espana E, Cervera M, Vila A, Navea A
Doc Ophthalmol. 1992; 82(4):297-305.
PMID: 1339115
DOI: 10.1007/BF00161017.